SCHEMBL6893071

SCHEMBL6893071

CC(CNCC(O)C(Cc1ccccc1)NC(=O)O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 9/20 0.57
SLC6A11 P48066 1/20 0.57
BCHE P06276 7/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7608787 1.00 BACE1 (0.57) BACE1SLC6A11BCHE
SCHEMBL7608795 1.00 BACE1 (0.57) BACE1SLC6A11BCHE
SCHEMBL7305633 0.89 BACE1 (0.60) BACE1SLC6A11BCHE
SCHEMBL7306846 0.89 BACE1 (0.60) BACE1SLC6A11BCHE
SCHEMBL3904429 0.88 BACE1 (0.59) BACE1SLC6A11BCHE
SCHEMBL5377459 0.88 BACE1 (0.59) BACE1SLC6A11BCHE
SCHEMBL5377462 0.88 BACE1 (0.59) BACE1SLC6A11BCHE
SCHEMBL3352792 0.88 BACE1 (0.54) BACE1SLC6A11BCHE
SCHEMBL3352784 0.88 BACE1 (0.54) BACE1SLC6A11BCHE
SCHEMBL2188440 0.88 BACE1 (0.54) BACE1SLC6A11BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed